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Abstract 
Objective: Evaluate best practice in managing anxiety in the pediatric population, including 
both school age children and adolescents. This literature review compared pharmacological 
treatment and cognitive behavioral therapy (CBT)’s effectiveness on the management of 
anxiety within the pediatric population. Background: Up to 25% of children in the United States 
are affected by a mental health disorder, anxiety being the most prevalent. Childhood anxiety 
can have a distressing impact on social, family, and academic functioning. If persisting into 
adulthood it increases the risk of developing other co-occurring mental health conditions, 
substance abuse issues, and contributes to impaired employment retention and socioeconomic 
burden. Addressing anxiety early has shown to have a lasting positive effect that carries 
forward into adulthood. Method: Five databases were selected to yield the highest levels of 
evidence. Key words from the clinical question were searched which generated the most 
prevalent hits. Sixty-five studies were identified, 16 were duplicates. Of the 49 studies 
reviewed, 22 met the inclusion criteria. A literature review of the 22 studies was conducted and 
synthesized. Results:  The combination of CBT and pharmacotherapy are far superior for 
pediatric anxiety than either treatment alone. Individually, CBT is more effective than 
pharmacotherapy with a longer lasting benefit and should be offered to all children with 
anxiety. Children with severe anxiety should utilize both CBT and pharmacotherapy as together 
they improve the likelihood of response and remission.  
Keywords: pediatrics, paediatrics, children, child, adolescents, youth, best practice, 
evidence based, assessment, screening, treatment, anxiety, anxiety disorder, mindfulness, CBT, 
cognitive behavioral therapy, outcome, non-pharmacological interventions, pharmacological 
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Childhood Anxiety: Cognitive Behavioral Therapy and/or Pharmacological Treatment 
The transition through childhood and into adulthood could be argued as one of the 
most vulnerable life experiences. Many healthcare providers now acknowledge the impact 
childhood experiences have on adulthood and realize the importance of facilitating this 
transition. After all, children are the future. Transitions of childhood have been well studied, 
developmental and functional stages well defined. There is a growing body of literature 
evaluating how childhood exposures impact lifelong outcomes and health in adulthood. 
Healthcare providers now know long-term eating behaviors are learned as a toddler; thus, it is 
critical to establish good eating habits at this age otherwise poor habits may lead to lifelong 
ramifications (Burns et al., 2017). Spanking is taught to have no place in the area of discipline 
due to the knowledge that children who receive spanking or physical force as a form of 
discipline are at much higher risk of developing physical force as a means to express anger and 
deal with conflict (Richardson, 2020). Providers also now have a greater understanding 
regarding the significance of adverse childhood events (ACEs). There are long-term associations 
between ACEs and adulthood health risks behaviors, health status, disease, and death (Felitti et 
al., 1998). Early adversity has a long-lasting impact as an adult and has the potential to 
influence many domains including injury, mental health, maternal health, infectious disease, 
chronic disease, risk behaviors, and life opportunities (Centers for Disease Control and 
Prevention [CDC], 2019). These examples emphasize that much of what occurs during 
childhood translates to who these individuals become as adults. One common co-occurrence in 
childhood and adulthood is the prevalence of anxiety. Adult psychosocial disorders can often be 
linked to childhood anxiety that persisted into adulthood. Childhood anxiety has been found to 
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predispose individuals to various health conditions and negatively impact functioning, making it 
an important consideration when caring for children and adolescents. 
Many factors contribute to the risk and onset of anxiety in childhood. There are, 
likewise, many issues childhood anxiety predisposes someone to developing as an adult. There 
are, however, effective ways of managing childhood anxiety to minimize the life lasting effect it 
may have. The treatment of childhood anxiety should be a shared decision between providers, 
patients, and parents. Everyone involved in decision-making should be well informed about the 
options available as well as their effectiveness and long-term outcomes on the diagnosis of 
anxiety. 
Background 
Common childhood anxiety disorders include social anxiety, generalized anxiety, 
obsessive-compulsive disorder (OCD), and separation anxiety (Burns et al., 2017). Roughly 20-
25% of children in the United States are affected by mental health or psychosocial problems 
(Burns et al, 2017; Wehry et al., 2015). Among mental health problems, anxiety is easily the 
most prevalent diagnosis (Adler Nevo et al., 2014; Crawford et al., 2013). More recent literature 
suggests a growing prevalence of childhood anxiety, reaching as high as 32% in the United 
States (Ege & Reinholdt-Dunne, 2016). It should be emphasized that although anxiety in 
childhood is labeled as a common condition, this does not translate as normal. There is a 
distinction to be made between the symptoms of anxiety, normally experienced by everyone at 
some point in their lives, and a persistent maladaptive behavior that classifies a diagnosis of 
anxiety. A formal anxiety diagnosis is not a normal developmental experience. 
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Misunderstanding this difference between normal anxiety symptoms and abnormal anxiety 
manifestation contributes to the underdiagnosing of childhood anxiety. It is disappointing that 
only 22% of adolescents who meet diagnostic criteria are diagnosed and treated by their 
primary care provider (Burns et al., 2017). This emphasizes a need for improvement in 
recognizing and managing anxiety.  
Nonetheless, it is relatively easy to understand how children fly under the radar of being 
diagnosed. Anxiety is often an internal process that may not be an obvious problem to those 
around the child, including parents, let alone a provider who sees them far less often (Boorady, 
2020). Children with anxiety may portray symptoms in a wide variety of ways. Often, they are 
labeled as inattentive or easily distracted. They may be fidgety or have behavioral outbursts. 
Sleep is a necessity for brain development and function (Burns et al., 2017), anxiety however, 
disrupts sleep and is known to contribute to sleep disorders. The disruption it causes in sleep 
may in part contribute to how anxiety is manifested clinically by the child. At the very least, the 
disturbance of sleep negatively impacts their anxiety symptoms. Additionally, children with 
anxiety commonly have a host of physical problems or complaints such as headaches, and 
stomachaches (Boorady, 2020). Though one exact cause of anxiety is unknown, it is likely 
multifactorial. The phrase ‘the apple doesn’t fall far from the tree’ is often referenced when 
comparing children to their parents. It is notable that children learn from their parents and 
children of anxious parents are at a much higher risk of developing an anxiety disorder 
themselves (Cartwright-Hatton et al., 2018). Anxiety may likely occur due to risk factors 
including genetics, a temperamental disposition such as shyness, social and/or environmental 
exposures, or life circumstances (Burns et al., 2017).  
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Untreated childhood anxiety can be very disabling and lead to chronic anxiety in 
adulthood. Childhood anxiety is known to negatively impact social and family functioning 
(Crawford et al., 2013). It additionally is the leading reason for school refusal, thus negatively 
impacting academics (Burns et al., 2017). Separation anxiety is a risk factor for panic attacks 
and disorders which can be very debilitating (Burns et al., 2017). Sustained anxiety into 
adulthood is concerning as it predisposes an individual to developing diverse psychiatric mood 
disorders and substance abuse disorders or dependence (Crawford et al., 2013). It is significant 
that approximately 32% of children with anxiety will carry this diagnosis forward with them into 
their adult years, making them susceptible to these co-occurring conditions (Burns & Thiessen, 
2014). Furthermore, sustained anxiety in adulthood is responsible for poor employment 
retention and outcomes (Adler Nevo et al., 2014). Anxiety not only causes individual distress 
and life-altering challenges, but it becomes an economic burden to society as well (Adler Nevo 
et al., 2014). Given anxiety disorders are among the most prevalent conditions affecting 
children and the distress it can cause on an individual and society, accurately diagnosing and 
treating anxiety should hold high importance in the minds of providers. Most cases of childhood 
anxiety are diagnosed before 12 years of age (Burns et al., 2017), 50% of cases occurring by six 
years of age (Ege & Reinholdt-Dunne, 2016). This early onset emphasizes the necessity for early 
screening and intervention to minimize risk of untreated or long-term effects of anxiety. 
Treatment of anxiety may include pharmacological therapies including selective serotonin 
reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and tricyclic 
antidepressants (TCAs). An underappreciated, yet effective, treatment includes CBT.  
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Of the treatment approaches available, CBT and SSRIs are viewed as the first line 
treatment options for childhood anxiety (De Souza et al., 2013). CBT has been one of the most 
extensively studied forms of psychotherapy (Butler et al., 2006). Regardless of it being proven 
to be an effective alternative modality in anxiety management, it remains underutilized 
compared to pharmacological interventions. CBT works by targeting and modifying cognitive 
dysfunction through psychotherapy using cognitive and behavioral techniques (Ege & 
Reinholdt-Dunne, 2016). It has been found to be effective in the management of several 
psychiatric disorders and has a lasting effect beyond the cessation of treatment (Butler et al., 
2006). CBT is most commonly administered through in-person therapy guided sessions. There 
are growing opportunities for CBT to be administered in a variety of settings including therapist 
guided parent-delivered sessions, school based, and computer or internet delivered. CBT is 
often delivered over a course of several weeks and is viewed as short-term therapy. Therapy 
sessions may range from 5-20 sessions depending on an individual’s need (Mayo, n.d.). Cost of 
CBT is often an initial concern. Although the cost of CBT varies, it has been found to be 
significantly lower than treatment as usual with pharmacotherapy (Dickerson et al., 2018). 
The goal of this literature review was to evaluate the best approach to managing 
childhood anxiety, specifically looking at pharmacological treatment verses CBT and if one 
modality is superior to the other or if a combined approach is most efficacious. The clinical 
question is: in school aged children (5-12 years old) and adolescents (12-18 years old) how does 
the efficacy of CBT compare to pharmacological treatments in the management of anxiety? This 
literature review also looked to answer an additional clinical question, including: What is the 
most effective tool in screening for childhood anxiety? Recurring themes found in the literature 
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were also reviewed in the synthesis. The results of this literature review are intended to inform 
providers of the best management approach for childhood anxiety and how to best carry out 
the recommended treatment. It is clinically significant to adequately treat childhood anxiety 
considering the prevalence of which anxiety is seen and therein reduce the risk untreated 
anxiety poses to this population as adults. More attention needs to be drawn to mental health 
in general, but particularly in the childhood population if providers are to make a lasting 
difference for the future.  
Methods 
In descending order, the best levels of evidence to evaluate an intervention question 
include systemic review/meta-analysis, randomized controlled trials (RCTs), non-RCTs, cohort 
studies or case-control studies, meta-syntheses of qualitative or descriptive studies, qualitative 
or descriptive single studies, and expert opinion (Melnyk & Fineout-Overholt, 2015). The 
databases identified for this literature review were aimed at collecting the highest level of 
evidence. Then, a broad database abstraction was done evaluating the hit results of the key 
terms derived from the PICO question. Based on the hit results, a literature review was 
conducted to screen for inclusion and exclusion criteria prior to synthesizing data. 
Databases 
The databases searched included Cochrane, CENTRAL, MEDLINE, CINAHL, and PsycINFO. 
Cochrane Database of Systemic Reviews is the gold standard database and should be among 
the first searched for intervention questions (Melnyk & Fineout-Overholt, 2015). Cochrane is 
where systemic reviews can be found in answering intervention questions. This is a smaller 
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database given it contains systemic reviews which are fewer and farther between. Another 
database that was searched included the CENTRAL database, which serves as the most 
comprehensive source of controlled trials. MEDLINE was a utilized database because it is the 
largest searchable database covering medicine and health. CINAHL database was used as it 
contains many subject areas, one being alternative/complimentary medicine which was an 
important component of the clinical question. Lastly, PsycINFO was another database explored 
given the mental health aspect of the clinical question. Refer to Table 1 in the appendix to 
visualize the databases used along with the corresponding restrictors, expanders, dates, and 
general subjects covered in the literature search.  
Search Strategy 
Each database was searched using the following key words, which were variations of the 
original clinical question, including; pediatrics, paediatrics, children, child, adolescents, youth, 
best practice, evidence based, assessment, screening, treatment, anxiety, anxiety disorder, 
mindfulness, CBT, cognitive behavioral therapy, outcome, non-pharmacological interventions, 
pharmacological. After the initial key word search, a correlating search strategy was applied. 
This strategy included a cross search, looking at the variations of the key terms and cross 
searching those results with each aspect of the PICO question. Lastly, a bibliography review was 
done on the studies that passed inclusion criteria. This process can be visualized in Table 2 of 
the appendix which shows the key words searched and the number of hits for the 
corresponding databases. Table 2 also demonstrates in bold the groups of articles reviewed for 
inclusion or exclusion. 
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Studies that evaluated CBT for anxiety as well as pharmacological treatment for anxiety 
were included in this review. Inclusion criteria was also dependent on age, including 
neurotypical pediatrics between 5-18 years old.  Studies pertaining to early childhood or adults 
outside the stated pediatric range of interest were excluded. Studies evaluating the therapies 
for conditions other than anxiety or studies evaluating these therapies for anxiety in the setting 
of another disorder, i.e., autism, PTSD, were excluded. This literature review looked to evaluate 
the effectiveness of CBT in comparison to pharmacological management of anxiety in the 
neurotypical pediatric population without other confounding factors. The exclusion criteria 
focused this review to yield the best results of treatment for anxiety disorders in pediatrics. In 
total, 65 studies were identified, 16 were duplicates, leaving 49 articles. Of the 49 articles that 
were reviewed, 22 met the inclusion criteria. Refer to Table 3 in the appendix for the studies 
included or excluded along with the rationale. 
The literature review process was conducted on all the included articles based on the 
method and inclusion/exclusion criteria. Table 4 summarizes the key aspects of the literature 
that were included and reviewed. Table 4 was developed prior the synthesis of data as a means 
data abstraction and organization.  
Methodological Strength 
 This literature review yielded quality evidence for the intervention question. Using the 
Hierarchy of Evidence (Melnyk & Fineout-Overholt, 2015), sixteen of the 22 articles (72%) were 
Level III evidence or higher, with the majority being Level II with RCTs accounting for 10 articles. 
One article met Level I evidence criteria as a systematic review. The second major grouping 
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being Level III which included five articles. The remaining five articles were Level IV evidence or 
lower.  
Literature Review 
Study Characteristics 
All studies evaluated the pediatric population, and the majority of studies evaluated 
both school-age children and adolescents between 7-18 years of age. The youngest age 
included in any of the studies was five years. Four studies looked specifically at school-age 
children (5-12 years). Four separate studies specifically looked at adolescents (10-17 years). The 
studies differed in the types of anxiety that were included, and this is acceptable due to the 
knowledge that often different anxiety types co-occur. The anxiety types found in the literature 
included various combinations of generalized anxiety, social anxiety, social phobia, and 
separation anxiety.  
As for the interventions, CBT and pharmacological treatment were the focus of interest. 
The studies evaluating CBT administered between 12-18, 60-minute sessions of CBT. The 
majority of studies developed their CBT protocol from The Coping Cat program. The original 
Coping Cat program involved 14 sessions over 12 weeks. Two were parent only and the 
remainder child sessions. The sessions included developing skills and training in anxiety 
management. This was followed by practice with anxiety provoking situations that were 
tailored to the participants needs and anxieties (Gonzalez et al., 2015). For those studies that 
evaluated pharmacotherapy, they almost exclusively utilized sertraline and had eight sessions 
for medication management and systematic adjustment in dosing. The tools most utilized by 
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the studies to obtain baseline assessment and post treatment outcomes were the Pediatric 
Anxiety Rating Scale (PARS) and the Screen for Child Anxiety Related Disorders (SCARED) 
anxiety screeners. PARS was used more than SCARED, seven studies to four respectively.  
CBT vs Pharmacotherapy Research Synthesis 
 CBT and SSRIs are known as the first line treatment options in the management of 
childhood anxiety. Within recent years research has expanded, evaluating their effectiveness, 
trying to identify the superior treatment options, and long-term outcomes. Although there is no 
agreement on which individual treatment (CBT or  SSRI) is more effective, the consensus of the 
literature is that CBT and pharmacotherapy together are far superior than either alone (Beidas 
et al., 2014; Burns & Thiessen, 2014; Walkup et al., 2008). Together, CBT and sertraline have 
response rates of 80% or higher (Beidas et al., 2014; Walkup et al., 2008). Given the high 
likelihood for success, it could be argued that combination therapy should be offered to all 
youth with anxiety disorders. The treatment approach could, however, be broken down based 
on the severity of the child’s anxiety. For children presenting with mild anxiety, all three 
therapies (combination or either CBT or SSRIs alone) are reasonable, producing favorable 
outcomes. Remission rates for combination therapy, sertraline alone, or CBT alone in mild 
anxiety can reach as high as 80% (Beidas et al., 2014). Untreated anxiety that progresses to 
moderate or severe anxiety decreases the responsiveness of therapy across the board. A 2014 
study found that for severe anxiety the response and resolution of their anxiety diagnosis 
varied between treatment groups, 62% responded to combination therapy, 49% responded to 
CBT alone, and only 27% responded to sertraline alone (Beidas et al., 2014). Additionally, higher 
levels of anxiety are associated with poorer long-term outcomes (Gibby, Casline, & Ginsburg, 
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2017). The reduced response rate and potential for poorer long-term outcome highlights the 
importance of early diagnosis and intervention to promote the best likelihood for success and 
remission of anxiety. If a patient is presenting with severe anxiety, providers should encourage 
combination therapy to increase the likelihood of response and improve outcomes (Beidas et 
al., 2014).  For milder presentations of anxiety, there is more leeway in the treatment choice. 
Findings show that with mild anxiety there is generally more favorable outcomes with any 
treatment, making all three options a reasonable starting point. This information can help 
facilitate the shared decision-making process by presenting the likelihood for success of each 
treatment option based on the severity of symptoms. These statistics further help to provide 
clear, easily digestible, and realistic expectations for families. However, there are a few 
exceptions to consider.  
CBT and pharmacotherapy together are superior, but if this is not a desired or feasible 
treatment approach then the literature suggests that CBT is superior to pharmacotherapy with 
a few exceptions. Nearly all studies in this literature review either found CBT to be superior to 
pharmacotherapy or at the very least equally effective.  As mentioned above, for school-age 
children and adolescents with severe anxiety, CBT was superior with a 49% response rate as 
compared to pharmacological treatment with a 27% response rate (Beidas et al., 2014). 
Another 2013 study evaluating CBT, medication, and combination therapy found similar results 
with CBT being superior to medication. Alone CBT had a 63.6% response rate whereas 
medication alone had a 50% response rate (Masi et al., 2013). More recent literature and a 
Cochrane review also supported that CBT appears to be more effective than treatment as usual, 
still there is a need for more research to definitively determine the superiority (James et al., 
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2018). The largest study to date evaluating pediatric anxiety involved 488 children and, not 
surprisingly, found the combination of CBT and sertraline to be more effective than either 
alone. The therapies alone had a response rate of 59.7% and 54% for CBT and sertraline 
respectively. Although this large study did not show a statistically significant difference, those 
receiving CBT had a lower dropout rate as well as less insomnia, fatigue, sedation, and 
restlessness than the sertraline group (Walkup et al., 2008). Considering the sertraline group 
had higher rates of side effects and dropouts, a limitation of this study was the potential for 
skewed results. Regardless, even though comparable in effectiveness, if side effects are a 
concern, CBT has proven to be an admirable alternative to pharmacological management. A 
notable theme favoring CBT is seen when reviewing separate studies looking specifically at 
these treatment options versus controls. CBT generally had higher rates of response, improved 
remission rates, and more favorable outcomes. Trials of CBT versus controls found response 
rates from 56%-95% (Chiu et al., 2013; De Souza et al., 2013; Galla et al., 2012) and remission 
rates up to 83% (Galla et al., 2012) versus controls response rates of 16-28% (De Souza et al., 
2013; Galla et al., 2012). As for medication versus controls, medication response rates remain 
around 50-55% in varying studies compared to a response rate around 24% in the control 
groups (Burns & Thiessen, 2014; Wehry et al., 2015). While not compared head on, this 
supports the suggestion that CBT has higher response and remission rates of anxiety, 
demonstrating its superiority.  
The exception of when CBT is not superior to pharmacotherapy is for children with a 
family history of anxiety. A positive family history of anxiety has been associated with a six-fold 
decrease in effectiveness of CBT compared to families without a family history of anxiety 
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(Gonzalez et al., 2015). When CBT versus sertraline was evaluated in the setting of anxious 
parents, the children receiving sertraline had more favorable responses (Gonzalez et al., 2015). 
Anxiety often clusters in families (Burns et al., 2017), thus this would be one exception where 
pharmacotherapy is the superior treatment choice. This knowledge allows for a more tailored 
and individualized approach with consideration of the child’s genetics and environment. With 
this being said, combination therapy remains superior, regardless of parental anxiety level 
(Gonzalez et al., 2015). 
Long-Term Outcomes 
Another consideration in choosing a treatment approach is the long-term effect and 
outcomes. Despite the fact that recent research indicates CBT is superior to pharmacotherapy, 
providers ultimately care about the long-term effect and prevention of anxiety into adulthood. 
The most recent research has been evaluating long-term outcomes and predictors of treatment 
success for both these treatment options. The therapeutic effects of CBT appear to persist, 
compared to pharmacological treatment, but evidence is limited (James et al., 2018). A long-
term follow-up study, with an average follow up at 50 months post treatment, found a 79% 
remission rate of those who received CBT versus no treatment (Brown et al., 2017). This 
indicates treatment gains are maintained for several years even after treatment is 
discontinued. It can be extrapolated that CBT may have a curative effect on childhood anxiety. 
This can be appreciated given the goal of CBT is to modify behavior and provide lifelong skills 
that may carry forward despite stopping treatment. A different study, with a six year follow up, 
found sustained effect with remission of anxiety for all treatment groups, including sertraline, 
CBT, and combination therapy (Wehry et al., 2015). Another study found that 76% no longer 
  16 
 
met diagnostic criteria of those who received either CBT or SSRI (Gibby et al., 2017). These two 
studies highlight that, regardless of treatment, there appears to be sustained long-term benefit 
if there is an initial treatment response. Only one long-term follow-up study of eight years had 
contradictory outcomes indicating that regardless of treatment or no treatment, there was a 
50% remission of anxiety diagnoses (Adler et al., 2014). These findings imply that there may be 
some childhood anxieties that spontaneously remit. However, that perspective remains a 
debate, and knowledge of who spontaneously remits is unknown.  
Researchers are beginning to evaluate potential predictors of treatment remission. 
Some factors, unfortunately, cannot always be predicted such as negative life events that have 
not yet occurred. Though the Adler et al (2014) eight-year follow up study concluded that 
childhood anxiety may improve without treatment, there may be bias. When collecting 
participants, researchers had far more participants from the non-treatment group decline 
participation at the eight-year follow up. This theoretically could have significantly skewed the 
data if it was hypothesized that the ones in the non-treatment group who declined 
participation were the ones who still carried an anxiety diagnosis. Adler et al. (2014) suggest 
that not all childhood anxiety needs to be treated and not all childhood anxiety will proceed 
into adulthood however there is no reliable means of deciphering which children are at risk. 
Given healthcare providers do not have good predictors and cannot forecast life events, this 
single study does not outweigh the potential benefit of treatment in light of the unknown 
variables. It does however raise question to the many unknowns about the long-term course of 
anxiety. Even though some believe anxiety may spontaneously remit, the general consensus is 
that children do not simply just outgrow their anxiety. The course of anxiety is a waxing and 
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waning process and is overall considered to be chronic and persistent, leading to psychiatric 
disorders in adulthood if left untreated (Wehry et al., 2015).   
Predictors of Treatment Success 
Despite best efforts to individualize care, it can be challenging to identify which 
treatment approach is best in each circumstance. Researchers continue to evaluate predictors 
of treatment success and factors that contribute to successful treatment outcomes. One study 
found that study participants with higher IQs have better responses to CBT (Benford, 2017). 
Moreover, concurrent family dysfunction or parenting stress have been correlated with poorer 
CBT response (Bunford, 2017). Children who are initial responders to treatment have been 
shown to have better long-term outcomes as compared to initial non-responders (Gibby et al., 
2017). Positive parental and patient expectations that treatment will lead to better outcomes is 
a robust predictor of adherence and positive outcomes (Zehgeer et al., 2018). Additionally, 
those living with two parents is another positive predictor of treatment adherence that impacts 
outcome (Zehgeer et al., 2018). Life events are another emerging predictor of outcomes, and 
those experiencing a greater number of negative life events have poorer outcomes (Gibby et 
al., 2017). Even still, life events may not be modifiable, so facilitating family coping strategies 
during such times is important.  Another factor contributing to outcomes is family 
accommodations (FA). FA behaviors include talking on behalf of the child, letting them sleep in 
their parents’ bed, providing special meals, facilitating and allowing school avoidance or 
avoidance of other activities. FAs have been shown to negatively impact child anxiety by 
maintaining anxiety as opposed to alleviating symptoms (Norman et al., 2015). Though 
unknown to the parent, these FAs negatively reinforce reliance on parents and hinder 
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independent growth and coping skills (Norman et al., 2015). Recognizing and educating parents 
on how these problematic behaviors impact treatment response and outcomes is needed. To 
date, of the longitudinal studies evaluating study subject’s post-treatment, none found that 
age, race, gender, or ethnicity had a clear impact on the duration of outcomes (Gibby et al., 
2017). 
These emerging predictors of treatment success can help guide treatment decisions 
though are in early stages of analysis. The most meaningful predictor at this time is baseline 
severity of anxiety predicting treatment response, as previously described (Beidas et al., 2014). 
Those with severe anxiety have lower success rates and higher rates of continued anxiety, 
which impact behaviors and psychological conditions in adulthood. This knowledge aids 
predicting outcomes and is meaningful for making informed decisions regarding the best 
treatment. It likewise allows for better communication and the ability to set reasonable 
expectations for long-term prognosis with families. Again, this information highlights the need 
to screen for early signs of anxiety and facilitate family functioning early on to achieve a more 
favorable treatment response and patient outcome. 
Recurring Themes of Literature to Aid Providers 
Screening for Childhood Anxiety 
 Unfortunately, it is not uncommon for the diagnosis of anxiety to be given more than 20 
years after symptom onset (James et al., 2018). Due diligence has not been achieved when it 
comes to screening childhood anxiety. Anxiety starts early in development with the median age 
of onset at six years old (Gibby et al., 2017) with social anxiety peaking in adolescents (James et 
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al., 2018). Clinical presentation varies greatly, hindering accurate diagnosis. Children likely 
present with somatic complaints of muscle tension, headaches, stomach aches, or anger 
outbursts (James et al., 2018). Often, children are first presenting in the nurse’s office at school 
with varying physical complaints (Burns & Thiessen, 2014). Other characteristics may include a 
shy disposition, soft spoken, avoidance of eye contact, rigid posture, blushing, or activity/school 
avoidance behaviors (Burns & Thiessen, 2014). It is important to remember that anxieties 
cluster in families, thus providers should screen carefully in children of anxious parents 
(Gonzalez et al., 2015). Children who present with any of these varying complaints should have 
anxiety as a leading differential. If organic disease is ruled out, then anxiety should be more 
thoroughly explored. Beyond symptom presentation, providers should be inquiring about 
anxiety routinely as often families are hesitant to disclose anxiety early on due to stigma or 
concern for judgement on their parenting style (Norman et al., 2015).   
A majority of the literature utilized the PARS or SCARED screening tool. PARS is a useful 
tool because it can benchmark treatment response. However, it is time intensive, it requires 
training for administration, (McGuire et al., 2019) and requires clinician grading (Wehry et al., 
2015). Whereas SCARED can similarly be used for monitoring treatment response, it is a youth- 
and parent-rated anxiety scale that requires minimal training and interpreting (McGuire et al., 
2019). SCARED is cost effective, as it is free and accessible online, and it has good reliability and 
validity. SCARED is recommended by NICE guidelines (Burns & Thiessen, 2014) and has the 
advantage of differentiating between different types of anxiety. In real world practice, SCARED 
is the favored screening tool for childhood anxiety though PARS is what is frequently utilized in 
trials (Wehry et al., 2015). 
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Treated vs Untreated   
 It is important to accurately diagnose anxiety early, but it is equally as important to treat 
it early. Early detection and intervention can prevent the development of abnormal behavioral 
patterns that interfere with functioning and lead to comorbidities in adulthood (Burns & 
Thiessen, 2014). Pediatrics who show positive response to initial treatment are far more likely 
to be anxiety free and less impaired in the long-term. Additionally, responders are significantly 
less likely to have depression and less likely to use marijuana or other substances (Gibby et al., 
2017). Children who were older when they first received treatment were more likely to need 
interim mental health services, further emphasizing earlier intervention is better (Gibby et al., 
2017). Untreated anxiety is a gateway illness for other lifelong adult psychiatric mood disorders. 
It is associated with higher rates of school dropout, and decreased quality of life, employment 
opportunity, and socioeconomic status. Additionally, with retained anxiety individuals are more 
likely to remain single and less likely to participate in life joys including social and leisure 
activities (Burns & Thiessen, 2014). Those with retained anxiety are also more prone to have 
children with anxiety given the tendency of clustering in families likely due to genetic and 
environmental factors (Burns et al., 2017). This literature review has highlighted the importance 
of treatment in light of all the potential negative outcomes that result from untreated anxiety.   
Barriers to CBT 
 Though CBT is superior, it is significantly underutilized in real world practice, primarily 
due to barriers. In fact, treatment for anxiety in general is significantly underutilized with only 
17% of children with anxiety receiving treatment in the United States (Salloum et al., 2016). 
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Barriers for CBT include lack of dissemination outside of specialty clinics and into community 
settings, geographic barriers, shortages of therapist, cost, need for ongoing therapy, and time 
consumption of therapy (Crawford et al., 2013; Salloum et al., 2016). Additionally, 
recommending CBT has proven to be a challenging barrier for providers on multiple levels due 
to lack of training, limited availability, large provider caseloads, and the varying clinical 
presentations impacting diagnosis (Crawford, et al., 2013). The common barrier from a parents’ 
perspective are that they either do not recognize their child’s problem as serious, they want to 
resolve the problem on their own, their worry about others knowing about treatment, or they 
simply don’t not know where to go (Salloum et al., 2016).  
Methods of CBT  
Historically, CBT has been done through in-person therapy sessions. More recently, 
smaller studies have evaluated the effectiveness of other treatment modalities for CBT. The 
good news is that CBT appears to be equally effective in various formats including family, 
individual, group, and online as well as across a variety of other settings (James et al., 2018). 
This has huge implications for management of childhood anxiety in addressing the many 
barriers to receiving in-person CBT. Receiving face-to-face therapist delivered CBT has been a 
challenge on many fronts including scheduling conflicts, availability, accessibility, 
transportation, and more. This is disappointing given how effective CBT is for childhood anxiety. 
Fortunately, recent studies have looked at delivering CBT in various formats and settings in 
attempt to expand its availability and minimize barriers to receiving this treatment with their 
effectiveness looking promising. 
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 A study from 2017 looked at computerized CBT and guided parent-delivered CBT and 
found these approaches are effective and have comparable outcomes to in-person therapy 
(Brown et al.). One study with therapist-guided internet delivered CBT with supplemented 
group and parent sessions had a 47% remission rate post treatment and 57% remission rate at 
6 months post treatment (Nordh et al., 2017). These findings demonstrated the continued 
benefit and effectiveness over time. Another study found computer-assisted CBT had an 86.7% 
remission rate and that parents and children were highly satisfied with the treatment approach 
(Crawford et al., 2013). Computer- and parent-guided CBT have the significant advantages of 
being flexible and easily incorporated into daily life at home. Another logical place for CBT is 
within schools. School settings of CBT have shown significant response. One study had an initial 
response rate of 95.5% and a 1-year remission rate of 83% while controls only had a response 
rate of 16.7% while on waitlist (Chiu et al., 2013; Galla et al., 2012). Beyond addressing some of 
the initial barriers to receiving CBT, there have been other added benefits. For instance, 
computer-delivered CBT has allowed for more individualized scenarios to be played out. This 
modality can expose the child to specific anxiety scenarios and allow them to play it out and 
practice behavior modification in a controlled setting (Burns & Thiessen, 2014). The 
effectiveness of these varying modalities and settings allows for more opportunity for the child 
and parent to receive CBT. 
Gaps in Literature 
 Several gaps in the research literature for childhood anxiety exist. To start, there is very 
little known about the natural course of anxiety. Debate exists between how much, if any, 
childhood anxiety spontaneously remits. There is varying literature on the different types of 
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childhood anxiety. Each study focused on varying combinations of the different types of anxiety 
including social, generalized, and separational anxiety as well as, OCD. It remains a possibility 
that each type of anxiety may have different long-term implications. However, it is difficult to 
isolate anxiety types due to the common co-occurrence they have with each other. Childhood 
anxiety is a known risk for varying conditions in adulthood, though predictors of which children 
will experience remission, and which will go on to develop adulthood conditions are in the early 
defining stages.  CBT has been proven to be an effective and superior treatment option with 
long lasting benefit. However, tackling barriers to receiving this treatment remains a gap in 
knowledge. Most recently, literature has explored different avenues of CBT settings and though 
results are promising, they are still in the early stages. These gaps in the research literature 
cloud providers interpretation and generalization of results into practice, highlighting the 
continued need for more research in this field.   
Discussion 
Childhood anxiety is common among the pediatric population and is associated with 
lifelong implications. An anxiety diagnosis in childhood risks the wellbeing of the patient’s acute 
health as well as their adult health. Adequate screening, diagnosing and treating childhood 
anxiety is in the best interest of not only the child but their family and society as well. Children 
are the future, addressing anxiety early has shown to have a lasting positive effect that carries 
forward into adulthood. The treatment of anxiety is very personal and should be individualized 
to incorporate the best evidence.   
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CBT and pharmacotherapy together are far superior in treating pediatric anxiety than 
either treatment alone. When these two treatments are compared alone, CBT is more effective 
than pharmacotherapy, with only a few exceptions. Additionally, CBT also has a longer lasting 
benefit that should be further explored in future research. Pharmacotherapy remains a 
respectable first line treatment option, but it is not the superior method and thus should not 
continue to be utilized as such in practice.  Rather, CBT and pharmacotherapy should be offered 
to all children with anxiety as first line treatment. Shared decision-making should be utilized 
when choosing the treatment regimen. Education on the expected response rates for the 
combination of CBT and pharmacotherapy as well as both options alone should be provided to 
families. This information will facilitate families in making informed decisions given their 
specific circumstances.  
The most meaningful information to guide treatment decisions is the severity of the 
child’s anxiety at the time of presentation. Pediatrics with severely rated anxiety should be 
strongly encouraged to receive a combination of CBT and pharmacotherapy. Together they 
improve the likelihood of response and remission for patients with severe anxiety, as neither 
CBT nor medication alone are as effective (62%, 49%, 27% response effectiveness respectively). 
Those with mild to moderately rated anxiety should still be offered the combination of 
treatments given its superiority, but there are more favorable and comparable outcomes for all 
three treatment options with non-severe anxiety. When combination therapy is not desired, if 
there is a strong family preference, family dysfunction, low patient IQ, or the patient has 
anxious parents, then pharmacotherapy should be offered. These are the only circumstances 
when pharmacotherapy has been shown to be superior to CBT. For everyone else, CBT is the 
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superior treatment for monotherapy. These deciding factors for treatment are highlighted in 
Figure 1. Beyond the treatment choice, there is importance to implementing treatment early 
after the onset of anxiety. In general, there are more favorable outcomes for those with mild to 
moderate anxiety if they receive treatment early, regardless of the treatment choice. Thus, 
treatment should be offered for all patients with a diagnosis of anxiety, no matter their 
severity.  
Implications for Future Practice 
Clinical Pearls 
Pediatric anxiety is highly prevalent yet significantly under-diagnosed and most often 
remains untreated. Diagnosing anxiety is hindered by the various and vague clinical 
presentations. It is also often underreported by family due to failure to recognize, concern of 
stigma, or writing it off as personality characteristic or shy disposition. Providers should be 
attentive to common presentations including various somatic complaints, shy disposition, 
avoidance of eye contact, history of school avoidance, frequent nurse visits, or children of 
anxious parents. If suspected, pediatric patients should be screened more carefully for an 
anxiety diagnosis. A quick two question method of screening may include: “Do you find yourself 
avoiding social situations or activities?” and “Are you fearful or embarrassed in social settings?” 
If answering yes to either question, then a more formal screening of either PARS or SCARED 
would be appropriate to more thoroughly screen for anxiety (Burns & Thiessen, 2014). If 
anxiety is present, there are very effective treatment options with high response and remission 
rates, but the key is to identify anxiety early for the best long-term outcome. If not dealt with, 
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chronic and persistent anxiety is considered a gateway to comorbidities in adulthood (Ege & 
Reinholdt-Dunne, 2016). Nonetheless, with early detection, treatment has success rates as high 
as 80% (Beidas et al., 2014). Those treated for childhood anxiety also have fewer anxiety-
related dysfunctions and disorders as an adult (Burns & Thiessen, 2014). The severity of anxiety 
at the time of diagnosis has some implication to the treatment recommendations. Of the 
treatment options available, the combination of CBT and an SSRI is the superior treatment 
approach across all severity levels. Those who receive combination therapy can consistently 
expect sustained and maintained reduction in their anxiety (Walkup et al., 2008). When both 
options cannot be utilized together, CBT has been shown to be superior to medication alone 
with its lasting effects and benefits (James et al., 2018). However, providers should remember 
that children with anxious parents benefit more from medication (Gonzalez et al., 2015). 
Additionally, multiple studies not only show high rates of response for CBT but high rates of 
remission and continued benefit for years after discontinuing treatment. An algorithm that 
highlights these clinical pearls and considerations has been developed based off this literature 
review to further guide providers in identifying and managing childhood anxiety, see Figure 1. 
One final clinical pearl is for providers to have a positive perception about treatment as this 
leads to better outcomes. In general, if patients and families have a positive perception about 
the treatment, they are more likely to have positive outcomes. The same is true for the 
opposite, since if they have a negative perception about treatment, they likely will have 
unfavorable outcomes. This emphasizes the importance of meeting family where they are. 
Providers need to identify modifications that can be done to overcome barriers of treatment 
and evaluate how to best address any concerns regarding treatment to yield the best outcome.  
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Referring to Cognitive Behavioral Therapy 
Cognitive behavioral therapy can be implemented as early as six years of age. The 
important component is that they have the cognitive capability to utilize the CBT techniques. 
Some studies have reported effectiveness in children younger than six years of age, but this is 
the exception and decision should be made on a case by case basis for those younger than six 
(James et al., 2018). There are multiple settings where CBT has been shown to be equally 
effective in; the one caveat being that other than face-to-face, these other treatment options 
are not yet widely accessible. Only recently has literature explored other practical solutions for 
implementing CBT besides face-to-face. Alternative modalities should be the future but 
currently their availability is limited. While awaiting these other modalities for CBT, working 
with families to overcome any barriers to receiving face-to-face therapy is optimal. It is worth 
noting that for the treatment of anxiety, CBT usually takes 9-20 sessions (James et al., 2018). 
The duration of CBT underlines the likely temporary need for treatment. This understanding 
may make it more realistic and feasible for families. As for the cost of CBT, it may range from 
$100-200 depending on the therapist. Of note, the cost of CBT has been found to be lower than 
treatment as usual with a statistically significant difference after the first year of CBT versus 
pharmacotherapy (Dickerson et al., 2018). The other modalities that have been recently studied 
have likewise shown cost savings, particularly with therapist-guided internet delivered CBT 
(ICBT).  ICBT includes minimal therapist assistance and has proven to be effective with 
substantial cost savings (Lenhard et al., 2017). ICBT allows for in home treatments at the parent 
or child’s convenience and eliminates many barriers to receiving CBT. Researchers and 
government agencies should focus their efforts on effectiveness and coverage of these 
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modalities since sustained anxiety has a long-lasting impact and leads to strained personal and 
national healthcare budgets (Lenhard et al., 2017). While awaiting these efforts, the 
recommended resources that have proven helpful for families include Timid to Tiger: A 
Treatment Manual for Parenting the Anxious Child (Norman et al., 2015) and The Coping Cat 
programs (Salloum et al., 2016). The Timid to Tiger manual is available online at no cost and can 
be utilized as a tool for parents of anxious children. The Coping Cat programs include the Camp 
Cope-A-Lot and Child Anxiety Tales and have the advantage of being completely computer 
driven with both a parent and child program available. Camp Cope-A-Lot is computer-delivered 
CBT, with therapist assistance, for children. The Child Anxiety Tales is computer-based parent 
training. The Coping Cat programs are available in 4-month or 12-month subscriptions, costing 
$99 or $125 respectively. The Coping Cat is also an excellent resource for providers. These three 
options, along with face-to-face CBT, are the current favored treatment approaches for CBT 
(James et al., 2018).   
Recommendations for Research 
 There are many areas in need of further research for childhood anxiety but since it has 
been well established that CBT is effective and even superior in some cases, efforts of research 
should be focused on how to make CBT more accessible. Dissemination of an effective 
technique for CBT is an important research field (De Souza et al., 2013).  Small studies have 
been done looking at the effectiveness of CBT in a variety of formats and settings. Larger 
studies evaluating these modalities should be done to confirm their effectiveness and further 
the plans for dissemination. ICBT is available and remains promising but few are utilizing it. 
Another potential promising setting for CBT is in schools. Those who work in schools are in an 
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ideal position to help recognize social anxiety (Burns & Thiessen, 2014). Children often present 
to the nurse’s office with varying complaints making school a likely place for the first signs of 
anxiety. Trials should be done for CBT delivered within schools, with similar style to how 
children receive speech therapy at school. CBT delivered at school would be ideal and help with 
overcoming common barriers to treatment (Chiu et al., 2013). Thinking to the future, more 
long-term studies should be conducted looking at relapse rates of anxiety when treated with 
CBT versus pharmacotherapy. If CBT has more of a curative effect by delivering behavioral 
modifications as opposed to a short-term effect of pharmacotherapy, this may drastically 
change future recommendations once CBT is more easily accessible.   
Recommendations for Education 
Evidence-based treatment is often slow to filter from research settings into the real-
world. There is another gap between educating about first line treatment options and the 
reality of how to obtain said treatment options. Academic centers should not only focus efforts 
on what are the first line treatment options, but how, as future providers, these options will be 
obtained. CBT is widely underutilized due to the lack of provider knowledge surrounding how to 
obtain this treatment approach. 
Recommendations for Policy 
Recommendations for policy largely surround the need for coverage of the cost for 
nonpharmacological interventions. One barrier to receiving CBT is the cost, even though in the 
long run CBT has substantial cost savings (Lenhard et al., 2017). It is imperative to address 
policy change and coverage at a government level because childhood anxiety impacts the 
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whole family function and can lead to anxiety and psychological conditions in adulthood. 
Moreover, the cycle could continue, and contribute to their future children’s potential for 
anxiety (Nordh et al., 2017). Anxiety runs a chronic, cyclical course if untreated, in turn 
negatively impacting the economy. Nordh et al. (2017) evaluated the impact of pretreatment 
anxiety on family functioning. They found that pretreatment, 27% of parents were staying 
home frequently due to their child’s anxiety. Childhood anxiety does not solely impact that 
child and their future, but rather the whole family and community around them. This in turn 
has a huge impact on the economy as a whole. It would be wise for policy change to occur to 
facilitate treatment of childhood anxiety.   
Conclusion 
Anxiety is incredibly prevalent among the pediatric population and is one disease that 
has been commonly overlooked and untreated. Most everyone experiences anxiety symptoms 
at some point in their lives, which may be in part why it is underdiagnosed. However, these 
normal fleeting anxiety symptoms are different than the dysfunctional emotional response 
seen in anxiety diagnoses (Ege & Reinholdt-Dunne, 2016). Considering anxiety is a dysfunctional 
emotional response, CBT is an obvious effective treatment for it is based on the concept that 
fear and anxiety are learned behaviors that can be unlearned (James et al., 2018). CBT differs 
from pharmacotherapy in that it is addressing the underlying maladaptive psychological 
thought process and is providing lifelong coping and adaptive skills. It has been shown to be 
more effective than pharmacology alone and is considered a first line treatment in childhood 
anxiety but is not being utilized as such. This must change. Ideally, prevention of childhood 
anxiety would be best. Providers should be encouraging nurturing parent-child relationships as 
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the early childhood years are the most critical for mental wellness (Burns et al., 2017). 
Providers should often inquire about mental health as many families are reluctant to share 
concerns spontaneously. Anticipatory guidance should not be overlooked as it becomes the 
building blocks for mental health in children. When the opportunity for primary prevention has 
been missed, providers must then rely on early detection and intervention. Mild anxiety 
followed by early intervention has the most likelihood of success and remission. If providers do 
not intervene, sustained anxiety will likely lead to significant impairment and become a strong 
risk factor for severe psychopathology in adulthood. The negative outcomes of untreated 
anxiety are not what providers intend for their pediatric patients’ futures. It is time for due 
diligence in tackling childhood anxiety and promoting pediatric mental health.  
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Figure 1 
Pediatric Anxiety Treatment Algorithm 
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Tables 1  
Database Search Description 
Database Restrictors/Expanders 
Added to Search 
Dates Included in 
Database 
General Subjects 
Covered in Database 
Cochrane Full Text, apply 
related words, search 
within text 
2009-2020 Contains articles and 
protocols focusing 
on the effects of 
healthcare and 
providing evidence-
based medicine data 
CENTRAL Abstract available 2009-2020 Controlled trials 
providing unbiased 
source of data and 
systemic review. 
MEDLINE Peer Reviewed, Full 
text, age 0-18 
(specified) 
2009-2020 Covers a variety of 
medical topics in 
various domains 
including medicine, 
nursing as well as 
dentistry and 
veterinary.  
CINAHL Full Text, Peer 
Reviewed 
2009-2020 Providers literature 
on nursing and allied 
health. 
PsycINFO Full Text, Peer 
Reviewed, Childhood 
(0-12), Adolescence 
(13-17) 
2009-2020 Provides literature 
about the disciplines 
related to 
psychology including; 
psychiatry, 
education, medicine 
nursing and more. 
(MSU, 2019) 
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Table 2  
Data Abstraction Process: Hit Results by Database 
Key Words Cochrane CENTRAL MEDLINE CINAHL PsycINFO 
“Mindfulness” 127/ 
8 (without 
expanders) 
3,644 1,443 2,019 826 
“Mindfulness” AND 
“Anxiety” 
117 1,343 395 X X 
“CBT” 236 5,416 1,250 X X 
“CBT” AND “Anxiety 205 2,344 496 X X 
“Cognitive 
Behavioral Therapy” 
AND “Anxiety” 
67 3,089 781 X X 
“Mindfulness” AND 
“Anxiety” AND 
“Pediatrics” 
16 18 
 
 
19/ 
2 (for age group 
0-18) 
7 14 
“CBT” AND 
“Anxiety” AND 
“Pediatrics” 
37 104 30/ 
4 (for age group 
0-18) 
25 149 
“Cognitive 
Behavioral Therapy” 
AND “Anxiety” AND 
“Pediatrics” 
13 
 
 
131 
 
 
34/ 
8 (for age group 
0-18) 
20 151 
“Treatment” AND 
“Pediatric” AND 
“Anxiety” AND 
“Mindfulness” 
27 8 0 3* 16 
“Treatment” AND 
“Pediatric” AND 
“Anxiety” AND 
“Cognitive 
Behavioral Therapy” 
122 
 
152 
 
 
7 19* 264 
“Outcome” AND 
“Pediatric” AND 
“Anxiety” AND 
“Mindfulness” 
27 13 1 5 11 
“Outcome” AND 
“Pediatric” AND 
“Anxiety” AND 
“Cognitive 
Behavioral Therapy” 
123 133 
 
 
7 11* 165 
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“Treatment” AND 
“Pediatric” AND 
“Anxiety” AND 
“Pharmacological” 
135 40 0 2* 55 
“Pediatric anxiety” 
AND “Treatment” 
AND “Evidence 
Based” 
1* 4* 14 27 122 
“Pediatric anxiety” 
AND “Treatment” 
AND “Evidence 
Based” AND 
“Mindfulness or 
Cognitive Behavioral 
Therapy” 
0 4* 2* 4* 9* 
“Assessment and 
Treatment” AND 
“Pediatric or Child” 
AND “Anxiety 
Disorder” 
166 7 14* 9* 54 
Correlating 
Strategy: 
“children OR child 
OR pediatric OR 
adolescent” AND 
“CBT OR cognitive 
behavioral therapy 
OR mindfulness” 
AND 
“pharmacological 
OR treatment OR 
management” AND 
“anxiety OR anxiety 
disorder” 
4 X 344 208/ 
44* 
(with 
exclusion 
criteria 
applied 
to 
search)  
619 
Bibliography Review 2* 
 
Note 
* BOLD= articles reviewed for inclusion and exclusion criteria.   
X= not searched in database 
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Table 3  
Characteristics of Literature Included and Excluded 
Reference Included
/ 
Excluded 
Rationale 
Adler Nevo, G.,W., Avery, D., Fiksenbaum, L., Kiss, A., 
Mendlowitz, S., Monga, S., & Manassis, K.  
(2014). Eight years later: Outcomes of CBT-treated versus 
untreated anxious children. Brain and Behavior, 4(5), 765-
774. https://doi.org/10.1002/brb3.274  
Included Long-term study 
evaluating effects 
of CBT 8 years 
post treatment 
vs none 
Beidas, R., S., Lindhiem, O., Brodman, D., M., Swan, A., Carper 
M, Cummings, C., Kendall, P.,  
Albano, A. M., Rynn, M., Piacentini, J., McCracken, J., 
Compton, S., March, J., Walkup, J., Ginsburg, G., Keeton, C. P., 
Birmaher, B., Skolsky, & D., Sherrill, J. (2014). A probabilistic 
and individualized approach for predicting treatment gains: 
An extension and application to anxiety disordered youth. 
Behavior Therapy, 45(1), 126–136. 
https://doi.org/10.1016/j.beth.2013.05.001  
Included Primary diagnosis 
of SAD or GAD 
according to DSM 
criteria.  
Evaluates CBT, 
CBT+ sertraline, 
sertraline, 
placebo 
Brown, A., Creswell, C., Barker, C., Butler, S., Cooper, P., 
Hobbs, C., & Thirlwall, K. (2017).  
Guided parent-delivered cognitive behaviour therapy for 
children with anxiety disorders: Outcomes at 3- to 5-year 
follow-up. The British Journal of Clinical Psychology, 56(2), 
149-159. https://doi.org/10.1111/bjc.12127  
Included Parent delivered 
CBT in childhood 
anxiety 
Bunford, N., Kujawa, A., Fitzgerald, K., Swain, J., Hanna, G., 
Koschmann, E., Simpson, D.,  
Connolly, S., Monk, C. S., & Phan, K. L. (2017). Neural 
reactivity to angry faces predicts treatment response in 
pediatric anxiety. Journal of Abnormal Child Psychology, 
45(2), 385–395. 
https://link.springer.com/article/10.1007/s10802-016-0168-2  
Included Evaluates 
predictors to why 
patients do not 
respond to 
pharmacotherap
y or CBT 
Burns, E., & Thiessen, K. (2014). Look closer ... I am not "just 
shy": Recognizing social anxiety  
disorder: A case study. NASN School Nurse, 29(6), 316-322.  
https://journals.sagepub.com/doi/10.1177/1942602X145454
81  
Included Case study 
reviewing 
screening tools 
based on age. 
Highlights school 
behaviors of 
children with 
anxiety 
Caporino, N., E., Morgan, J., Beckstead, J., Phares, V., 
Murphy, T., K., & Storch, E., A. (2012). A structural equation 
Excluded Evaluating family 
accommodations 
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analysis of family accommodation in pediatric obsessive-
compulsive disorder. Journal of Abnormal Child Psychology, 
40(1), 133–143. https://doi.org/10.1007/s10802-011-9549-8  
for obsessive 
compulsive 
disorder 
Cartwright-Hatton, S., Ewing, D., Dash, S., Hughes, Z., 
Thompson, E. J., Hazell, C. M., Field, A. P.,  
& Startup, H. (2018). Preventing family transmission of 
anxiety: Feasibility RCT of a brief intervention for parents. 
The British Journal of Clinical Psychology, 57(3), 351-366. 
https://doi.org/10.1111/bjc.12177  
Excluded 
 
Study evaluating 
parents with 
anxiety and 
likelihood of child 
developing 
anxiety 
Chiu, A., Langer, D., Mcleod, B., Har, K., Drahota, A., Galla, B., 
Jacobs, J., Ifekwunigwe, M., &  
Wood, J. (2013). Effectiveness of modular CBT for child 
anxiety in elementary schools. School Psychology Quarterly, 
28(2), 141–153. https://doi.org/10.1037/spq0000017  
Included Clinical trial 
performed in 
elementary 
school using CBT. 
Crawford, E. A., Salloum, A., Lewin, A. B., Andel, R., Murphy, 
T. K., & Storch, E. A. (2013). A pilot  
study of computer-assisted cognitive behavioral therapy for 
childhood anxiety in community mental health centers. 
Journal of Cognitive Psychotherapy, 27(3), 221-234. 
https://doi.org/10.1891/0889-8391.27.3.221  
Included Pilot study 
looking at 
computer 
assisted CBT in 
the community 
for childhood 
anxiety 
De Souza, M., Augusta Mansur, Salum, G. A., Jarros, R. B., 
Isolan, L., Davis, R., Knijnik, D., Manfro, G. G., & Heldt, E. 
(2013). Cognitive-behavioral group therapy for youths with 
anxiety disorders in the community: Effectiveness in low and 
middle income countries. Behavioural and Cognitive 
Psychotherapy, 41(3), 255-264. 
https://doi.org/10.1017/S1352465813000015  
Included CBT is a known 
treatment option 
for pediatric 
anxiety, but little 
known about 
low- and middle-
income families  
Ege, S., & Reinholdt-Dunne, M. L. (2016). Improving 
treatment response  
for paediatric anxiety disorders: An information-processing 
perspective. Clinical Child & Family Psychology Review, 19(4), 
392–402. https://doi.org/10.1007/s10567-016-0211-4  
Included Review examines 
informational 
processing biases  
Galla, B. M., Wood, J. J., Chiu, A. W., Langer, D. A., Jacobs, J., 
Ifekwunigwe. M., & Larkins, C.  
(2012). One year follow-up to modular cognitive behavioral 
therapy for the treatment of pediatric anxiety disorders in an 
elementary school setting. Child Psychiatry and Human 
Development, 43(2), 219–226. 
https://doi.org/10.1007/s10578-011-0258-x  
Included Long-term effect 
of CBT post-
delivery in 
elementary 
school setting. 
Evidence of 
ongoing 
advantage post 1 
year of CBT 
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Gibby, B., Casline, E., & Ginsburg, G. (2017). Long-term 
outcomes of youth treated for an  
anxiety disorder: A critical review. Clinical Child & Family 
Psychology Review, 20(2), 201–225. 
https://doi.org/10.1007/s10567-017-0222-9  
Included Evaluates long-
term effect of 
medication and 
CBT 
Gonzalez, A., Peris, T. S., Vreeland, A., Kiff, C. J., Kendall, P. C., 
Compton, S. N., Albano, A. M.,  
Birmaher, B., Ginsburg, G. S., Keeton, C. P., March, J., 
McCracken, J., Rynn, M., Sherrill, J., Walkup, J. T., & 
Piacentini, J. (2015). Parental anxiety as a predictor of 
medication and CBT response for anxious youth. Child 
Psychiatry & Human Development, 46(1), 84–93. 
https://doi.org/10.1007/s10578-014-0454-6  
Included Parental 
influence on 
treatment of 
pediatric anxiety 
Hoffman, L. J., Guerry, J. D., & Albano, A. M. (2018). 
Launching anxious young adults: A specialized cognitive-
behavioral intervention for transitional aged youth. Current 
Psychiatry Reports, 20(4), 1. https://doi.org/10.1007/s11920-
018-0888-9  
Excluded Transition of 
young adults and 
CBT. 
Excluded due to 
age, 18-25yr 
Højgaard, D., Skarphedinsson, G., Nissen, J., Hybel, K., 
Ivarsson, T., & Thomsen, P. (2017). Pediatric obsessive-
compulsive disorder with tic symptoms: clinical presentation 
and treatment outcome. European Child & Adolescent 
Psychiatry, 26(6), 681–689. https://doi.org/10.1007/s00787-
016-0936-0  
Excluded Evaluating 
obsessive 
compulsive 
disorder, not 
GAD 
James, A. C., James, G., Cowdrey, F. A., Soler, A., Choke, A., & 
James, A. C. (2018). Cognitive  
behavioural therapy for anxiety disorders in children and 
adolescents. Cochrane Database of Systematic Reviews, (2). 
https://doi.org/10.1002/14651858.CD004690.pub4  
Included Examines CBT vs 
controls vs 
medication vs 
combo. All RCT. 
Compared 
individual, group 
and family CBT 
 
Keeton, C. P., Kolos, A. C., & Walkup, J. T. (2009). Pediatric 
generalized anxiety disorder: Epidemiology, diagnosis, and 
management. Paediatric Drugs, 11(3), 171-183. 
https://doi.org/10.2165/00148581-200911030-00003  
Excluded Full text not 
available. Does 
not meet criteria 
Klein, A. M., Müller-Göttken, T., White, L. O., Keitel-
Korndörfer, A., & von Klitzing, K. (2015). Summary of the pilot 
study short-term psychoanalytic child therapy (PaCT) of 
anxious children]. Praxis Der Kinderpsychologie Und 
Kinderpsychiatrie, 64(7), 563-571. 
https://doi.org/10.13109/prkk.2015.64.7.563  
Excluded Pilot study 
evaluating 
psychoanalytic 
therapy, not CBT 
or mindfulness 
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Knight, S., Harvey, A., Towns, S., Payne, D., Lubitz, L., Rowe, 
K., Reveley, C., Hennel, S., Hiscock, H., & Scheinberg, A. 
(2014). How is paediatric chronic fatigue syndrome/myalgic 
encephalomyelitis diagnosed and managed by paediatricians? 
An Australian Paediatric Research Network Study. Journal of 
Paediatrics & Child Health, 50(12), 1000–1007. 
https://doi.org/10.111/jpc.12677  
Excluded Evaluating 
chronic fatigue, 
not pediatric 
anxiety. 
Law, E. F., Beals, E. S. E., Noel, M., Claar, R., & Palermo, T. M. 
(2015). Pilot randomized controlled trial of internet-delivered 
cognitive-behavioral treatment for pediatric headache. 
Headache: The Journal of Head & Face Pain, 55(10), 1410–
1425. https://doi.org/10.1111/head.12635  
Excluded Evaluating CBT 
for pediatric 
headaches, not 
anxiety 
Lenhard, F., Ssegonja, R., Andersson, E., Feldman, I., Rück, C., 
Mataix-Cols, D., & Serlachius, E.  
(2017). Cost-effectiveness of therapist-guided internet-
delivered cognitive behaviour therapy for paediatric 
obsessive-compulsive disorder: Results from a randomised 
controlled trial. BMJ Open, 7(5), 1. 
https://doi.org/10.1136/bmjopen-2016-015246  
Included Internet guided 
CBT for 
adolescents. 
Evaluating cost 
effectiveness 
Masi, G., Pfanner, C., Mucci, M., Berloffa, S., Magazu, A., 
Parolin, G., Perugi, G. (2013). Pediatric  
social anxiety disorder: Predictors of response to 
pharmacological treatment. Brown University Child & 
Adolescent Psychopharmacology Update, 15(2), 7. 
https://doi.org/10.1089/cap.2012.0007  
Included Evaluates 
pharmacological 
approach to 
anxiety 
management and 
predictors of 
success 
McGuire, J. F., Caporino, N. E., Palitz, S. A., Kendall, P. C., 
Albano, A. M., Ginsburg, G. S.,  
Birmaher, B., Walkup, J., & Piacentini, J. (2019). Integrating 
evidence-based assessment into clinical practice for pediatric 
anxiety disorders. Depression & Anxiety, 36(8), 744–752. 
https://doi.org/10.1002/da.22900  
Included Evidence based 
assessment of 
clinical practice 
for pediatric 
anxiety 
Misri, S., Abizadeh, J., Sanders, S., & Swift, E. (2015). Perinatal 
generalized anxiety disorder: Assessment and Treatment. 
Journal of Women’s Health (15409996), 24(9), 762–770. 
https://doi.org/10.1089/jwh.2014.5150  
Excluded Perinatal anxiety, 
not pediatric 
anxiety 
Nadeau, J. M., Jacob, M. L., Keene, A. C., Alderman, S. M., 
Hacker, L. E., Cavitt, M. A., Alvaro, J., & Storch, E. A. (2015). 
Correlates and mediators of life satisfaction among youth 
with attention-deficit/hyperactivity disorder. Children’s 
Health Care, 44(2), 169–182. 
https://doi.org/10.1080/02739615.2014.896215  
Excluded Evaluating ADHD, 
not pediatric 
anxiety 
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Nakagawa, A., Grunebaum, M. F., Oquendo, M. A., Burke, A. 
K., Kashima, H., & Mann, J. J. (2009). Clinical correlates of 
planned, more lethal suicide attempts in major depressive 
disorder. Journal of Affective Disorders, 112(1-3), 237-242. 
http://doi.org/10.1016/j.jad.2008.03.021  
Excluded Evaluating 
suicide rate 
among 
adolescents with 
depression 
NCT03269370. (2017). Family-focused CBT skills app and 
standard self help options for childhood anxiety. 
Https://Clinicaltrials.Gov/Show/Nct03269370  
Excluded Study has not yet 
been conducted.  
Proposal abstract 
evaluating 
effectiveness of 
an App for family 
guided CBT 
NCT03585010. (2018). Brain response associated with parent-
based treatment for childhood anxiety disorders. 
Https://Clinicaltrials.Gov/Show/Nct03585010  
Excluded Study is not 
evaluating CBT, 
but rather SPACE 
(support 
parenting for 
anxious 
childhood 
emotions) 
 Nordh, M., Vigerland, S., Öst, L., Ljótsson, B., Mataix-Cols, D., 
Serlachius, E., & Högström, J.  
(2017). Therapist-guided internet-delivered cognitive-
behavioural therapy supplemented with group exposure 
sessions for adolescents with social anxiety disorder: A 
feasibility trial. BMJ Open, 7(12), 1. 
https://doi.org/10.1136/bmjopen-2017-018345  
Included Goal of study to 
evaluate 
feasibility of 
therapist guided 
internet-based 
CBT with 
supplemented 
group 
Norman, K. R., Silverman, W. K., & Lebowitz, E. R. (2015). 
Family accommodation of child and  
adolescent anxiety: Mechanisms, assessment, and treatment. 
Journal of Child & Adolescent Psychiatric Nursing, 28(3), 131–
140. https://doi.org/10.1111/jcap.12116  
Included Family 
accommodations 
for assessment 
and treatment 
Ollendick, T. H., Ryan, S. M., Capriola-Hall, N. N., Salazar, I. C., 
& Caballo, V. E. (2019). Evaluation of the reliability and 
validity of the social anxiety questionnaire for children in 
adolescents with social anxiety disorder. Journal of 
Psychopathology & Behavioral Assessment, 41(1), 16–24. 
https://doi.org/10.1007/s10862-018-9699-x  
Excluded Evaluating SAD 
screener tools, 
not effectiveness 
of treatment. 
Ori, R., Amos, T., Bergman, H., Soares-Weiser, K., Ipser, J. C., 
& Stein, D. J. (2015). Augmentation of cognitive and 
behavioural therapies (CBT) with d-cycloserine for anxiety 
and related disorders. The Cochrane Database of Systematic 
Excluded Full text not 
available. Not 
pediatric 
  47 
 
Reviews, (5), 1. 
https://doi.org/10.1002/14651858.CD007803.pub2  
population 
focused. 
Pajer, K. A., Gardner, W., Lourie, A., Chang, C., Wang, W., & 
Currie, L. (2014). Physical child abuse potential in adolescent 
girls: Associations with psychopathology, maltreatment, and 
attitudes toward child-bearing. Canadian Journal of 
Psychiatry.Revue Canadienne De Psychiatrie, 59(2), 98-106. 
https://doi.org/10.1177/070674371405900205  
Excluded Evaluating child 
abuse potential, 
not childhood 
anxiety 
Panganiban, M., Yeow, M., Zugibe, K., & Geisler, S. L. (2019). 
Recognizing, diagnosing, and treating pediatric generalized 
anxiety disorder. JAAPA : Official Journal of the American 
Academy of Physician Assistants, 32(2), 17-21. 
https://doi.org/10.1097/01.JAA.0000552719.98489.75  
Excluded Full text not 
available. 
Reigada, L. C., Benkov, K. J., Bruzzese, J.-M., Hoogendoorn, C., 
Szigethy, E., Briggie, A., Walder, D. J., & Warner, C. M. (2013). 
Integrating illness concerns into cognitive behavioral therapy 
for children and adolescents with inflammatory bowel 
disease and co-occurring anxiety. Journal for Specialists in 
Pediatric Nursing, 18(2), 133–143. 
https://doi.org/10.1111/jspn.12019  
Excluded Evaluating CBT 
for inflammatory 
bowel disease 
and co-occurring 
anxiety 
Roos, C., Oord, S., Zijlstra, B., Lucassen, S., Perrin, S., 
Emmelkamp, P., & Jongh, A. (2017). Comparison of eye 
movement desensitization and reprocessing therapy, 
cognitive behavioral writing therapy, and wait-list in pediatric 
posttraumatic stress disorder following single-incident 
trauma: a multicenter randomized clinical trial. Journal of 
Child Psychology & Psychiatry, 58(11), 1219–1228. 
https://doi.org/10.1111/jcpp.12768  
Excluded Evaluating CBT 
and PTSD 
Rusch, H. L., Shvil, E., Szanton, S. L., Neria, Y., & Gill, J. M. 
(2015). Determinants of psychological resistance and 
recovery among women exposed to assaultive trauma. Brain 
and Behavior, 5(4), 1. https://doi.org/10.1002/brb3.322  
Excluded Evaluating 
women exposed 
to traumatic 
events and risk of 
developing 
psychiatric 
disorder  
Salloum, A., Johnco, C., Lewin, A. B., McBride, N. M., & 
Storch, E., A. (2016). Barriers to access  
and participation in community mental health treatment for 
anxious children. Journal of Affective Disorders, 196, 54–61. 
https://doi.org/10.1016/j.jad.2016.02.026  
Included Examines 
barriers to CBT 
for anxiety. 
Community 
based RCT. 
Results, parents 
don’t know 
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where to seek 
care.  
Smith-Schrandt, H., & Ellington, E. (2018). Unable to speak: 
Selective mutism in youth. Journal of Psychosocial Nursing 
and Mental Health Services, 56(2), 14-18. 
https://doi.org/10.3928/02793695-20180122-04  
Excluded Evaluating clinical 
characteristics 
and 
recommendation
s for selective 
mutism 
Soussana, M., Sunyer, B., Pry, R., & Baghdadli, A. (2012). 
Anxiety in children and adolescents with pervasive 
developmental disorder without mental retardation: Review 
of literature]. L'Encephale, 38(1), 16-24. 
https://doi.org/10.1016/j.encep.2011.05.007  
Excluded Full text not 
available. 
Evaluating PDD 
as opposed to 
anxiety 
Stapersma, L., van den Brink, G., van der Ende, J., Szigethy, E. 
M., Beukers, R., Korpershoek, T. A., Theuns-Valks, S. D., 
Hillegers, M., Escher, J., & Utens, E. M. W. J. (2018). 
Effectiveness of disease-specific cognitive behavioral therapy 
on anxiety, depression, and quality of life in youth with 
inflammatory bowel disease: A randomized controlled trial. 
Journal of Pediatric Psychology, 43(9), 967–980. 
https://doi.org/10.1093/jpepsy/jsy029  
Excluded Evaluating CBT 
for depression 
and Irritable 
Bowl Disease, not 
pediatric anxiety 
Walkup, J. T., Albano, A. M., Piacentini, J., Birmaher, B., 
Compton, S. N., Sherrill, J. T., Ginsburg,  
G., Rynn, M., McCracken, J., Waslick, B., Lyengar, S., March, J. 
S., & Kendall, P. C. (2008). Cognitive behavioral therapy, 
sertraline, or a combination in childhood anxiety. The New 
England Journal of Medicine, 359(26), 2753-66. 
https://doi.org/10.1056/NEJMoa0804633  
Included CAMS trial often 
referred to in 
other literature. 
Largest RCT of 
pediatric anxiety 
to date 
Wehry, A. M, Beesdo-Baum, K., Hennelly, M. M., Connolly, S. 
D., & Strawn, J. R. (2015).  
Assessment and treatment of anxiety disorders in children 
and adolescents. Current Psychiatry Reports, 17(7). 
https://doi.org/10.1007/s11920-015-0591-z  
Included Evaluates current 
epidemiology, 
longitudinal 
trajectory of 
anxiety disorder 
in youth; 
including CBT vs 
medication  
White, L. K., Sequeira, S., Britton, J. C. Brotman, M. A., Gold, 
A. L., Berman, E, Towbin, K., Abend, R., Fox, N., Bar-Haim, Y., 
Leibenluft, E., & Pine, D. S. (2017). Complementary features 
of attention bias modification therapy and cognitive-
behavioral therapy in pediatric anxiety disorders. American 
Journal of Psychiatry, 174(8), 775–784. 
https://doi.org/10.1176/appi.ajp.2017.16070847  
Excluded Study is 
examining 
Attention Bias 
Modification 
Therapy.  
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Zavadenko, N. N., Simashkova, N. V., Vakula, I. N., 
Suvorinova, N. Y., Balakireva, E. E., & Lobacheva, M. V. 
(2015). Current possibilities in pharmacotherapy of anxiety 
disorders in children and adolescents]. Zhurnal Nevrologii i 
Psikhiatrii Imeni S.S.Korsakova, 115(11), 33-39. 
http://doi.org/10.17116/jnevro201511511133-39  
Excluded Article not 
available in 
English 
Zehgeer, A., Ginsburg, G. S., Lee, P., Birmaher, B., Walkup, J., 
Kendall, P. C., Sakolsky, D., Peris, T.  
(2018). Pharmacotherapy adherence for pediatric anxiety 
disorders: Predictors and relation to child outcomes. Child & 
Youth Care Forum, 47(5), 633-644. 
https://doi.org/10.1007/s10566-018-9459-9  
Included Evaluates 
adherence of 
treatment for 
pediatric anxiety 
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Table 4  
Literature Review Table of All Included Studies 
Citation Study 
Purpose 
Pop/ 
Sample 
Size 
Design/ 
Level of 
Evidence 
Variables/ 
Instruments 
Intervention Findings Implication 
Adler Nevo, G.,W., 
Avery, D., 
Fiksenbaum, L., Kiss, 
A., Mendlowitz, S., 
Monga, S., & 
Manassis, K.  
(2014). Eight years 
later: Outcomes of 
CBT-treated versus 
untreated anxious 
children. Brain and 
Behavior, 4(5), 765-
774. 
https://doi.org/10.10
02/brb3.274  
To 
evaluate 
the long-
term 
impact of 
CBT 
treatmen
t vs none 
in the 
manage
ment of 
childhoo
d anxiety 
N=120. 
Ages; 
8-12 
years 
Level 2; 
RCT 
Subjects 
who had 
previously 
received 
some form 
of CBT in 
the past 
were 
excluded 
Treated 
children 
received 12 
sessions of 
group CBT or 
individual with 
parent 
sessions 
utilizing the 
“Coping Bear” 
manual 
“Coping Cat” 
protocol. Semi 
structured 
interviews 
upon follow up 
Anxiety levels 
were found to 
be significantly 
lower in the 
nontreatment 
group. This 
suggest that 
some childhood 
anxiety may 
remit 
spontaneously 
over time. 
First long-term 
study evaluating 
CBT treatment for 
anxiety in children 
and long-term 
outcomes. 
Results are 
interesting because 
long-term outcome 
is better for those 
who didn’t receive 
treatment. Study 
looked at those 
with separational, 
generalized or 
social anxiety. 
Beidas, R., S., 
Lindhiem, O., 
Brodman, D., M., 
Swan, A., Carper M, 
Cummings, C., 
Kendall, P.,  
Albano, A. M., Rynn, 
M., Piacentini, J., 
McCracken, J., 
Evaluate 
the 
probabilit
y of 
treatmen
t benefit 
of 
multiple 
treatmen
N=488. 
Ages; 
7-17 
years 
Level 2; 
RCT 
Participants 
were from 
the CAMS 
trial. 
Recruited 
by variety of 
means 
(flyers, TV, 
CBT, sertraline, 
CBT + 
sertraline, 
placebo 
Combination of 
CBT and 
sertraline were 
superior than 
either 
monotherapy 
but only for 
moderate/sever
e cases of 
For moderate to 
severe anxiety 
multiple treatment 
approaches should 
be implemented. 
For mild anxiety 
there may not be a 
superior first line 
and patient/parent 
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Compton, S., March, 
J., Walkup, J., 
Ginsburg, G., Keeton, 
C. P., Birmaher, B., 
Skolsky, & D., Sherrill, 
J. (2014). A 
probabilistic and 
individualized 
approach for 
predicting treatment 
gains: An extension 
and application to 
anxiety disordered 
youth. Behavior 
Therapy, 45(1), 126–
136. 
https://doi.org/10.10
16/j.beth.2013.05.001  
t 
approach
es 
radio ads, 
website) 
anxiety. For mild 
anxiety, all three 
treatments were 
comparable. 
preference should 
be considered. 
Brown, A., Creswell, 
C., Barker, C., Butler, 
S., Cooper, P., Hobbs, 
C., & Thirlwall, K. 
(2017).  
Guided parent-
delivered cognitive 
behaviour therapy for 
children with anxiety 
disorders: Outcomes 
at 3- to 5-year follow-
up. The British Journal 
of Clinical Psychology, 
Evaluate 
long-
term 
outcome
s (3-5 
years 
posttreat
ment) of 
parent 
delivered 
CBT for 
childhoo
N=57. 
Ages; 
11-17 
years 
Level 4; 
Long-
term 
follow up 
cohort 
study 
Participants 
of previous 
trial.  Parent 
delivered. 
Parents 
provided 
self-help 
book and 
two forms 
of therapy 
support 
Parent guided 
CBT. 
Overcoming 
your child’s 
fears and 
worries’; 
Creswell & 
Willetts, 2007 
At the time of 
the long-term 
follow up, 79% 
of CBT 
participants no 
longer met DSM 
criteria for 
anxiety 
CBT appears to 
have long-term 
effect and may 
resolve anxiety 
diagnosis in 
childhood anxiety. 
Parent delivered 
CBT is a reasonable 
approach and 
should be further 
explored and 
supported 
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56(2), 149-159. 
https://doi.org/10.11
11/bjc.12127  
d anxiety 
disorders 
Bunford, N., Kujawa, 
A., Fitzgerald, K., 
Swain, J., Hanna, G., 
Koschmann, E., 
Simpson, D.,  
Connolly, S., Monk, C. 
S., & Phan, K. L. 
(2017). Neural 
reactivity to angry 
faces predicts 
treatment response in 
pediatric anxiety. 
Journal of Abnormal 
Child Psychology, 
45(2), 385–395. 
https://link.springer.c
om/article/10.1007/s
10802-016-0168-2  
Pharmac
otherapy 
and CBT 
are 
known 
treatmen
t 
approach
es to 
pediatric 
anxiety, 
this study 
evaluates 
what 
predicts 
treatmen
t 
response 
N=52. 
Ages; 
7-18 
years 
Level 4; 
Case 
control 
Participants 
self-
selected 
group 
SSRI, CBT. 
PARS anxiety 
tool. 
Emotional 
Face-Matching 
Task 
Higher LPP to 
angry faces was 
associated with 
lower post 
treatment 
anxiety however 
did not differ 
between 
treatment types 
(CBT vs SSRI) 
ERPs are potentially 
useful indicates to 
treatment 
response, though 
not in 
differentiating 
between most 
effective treatment 
Burns, E., & Thiessen, 
K. (2014). Look closer 
... I am not "just shy": 
Recognizing social 
anxiety  
disorder: A case study. 
NASN School Nurse, 
29(6), 316-322.  
Case 
study to 
highlight 
the 
classic 
character
istics of 
children 
with 
anxiety 
NA Level 6; 
Case 
Study 
NA Screening tools 
based on age, 
SSRIs, SNRIs, 
other 
antidepressant
, 
psychotherapy 
NA Provides 
recommendations 
for school 
assessments. 
Highlights common 
school behaviors of 
children with 
anxiety 
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https://journals.sagep
ub.com/doi/10.1177/
1942602X14545481  
within 
the 
school 
setting 
  Chiu, A., Langer, D., 
Mcleod, B., Har, K., 
Drahota, A., Galla, B., 
Jacobs, J., 
Ifekwunigwe, M., &  
Wood, J. (2013). 
Effectiveness of 
modular CBT for child 
anxiety in elementary 
schools. School 
Psychology Quarterly, 
28(2), 141–153. 
https://doi.org/10.10
37/spq0000017  
Clinical 
trial 
evaluativ
e CBT for 
anxiety, 
performe
d within 
the 
school 
setting. 
N=40. 
Ages; 
5-12 
years 
Level 2; 
RCT 
Building 
confidence 
intervention
, ADIS-C/P. 
Study 
conducted 
at two 
elementary 
schools 
CBT Nearly all 
children, 95.5% 
no longer met 
criteria for 
anxiety disorder 
post treatment. 
Statistically 
significant 
results. 
Clinicians and 
researches should 
consider 
implementation of 
CBT within 
elementary school 
settings  
Crawford, E. A., 
Salloum, A., Lewin, A. 
B., Andel, R., Murphy, 
T. K., & Storch, E. A. 
(2013). A pilot  
study of computer-
assisted cognitive 
behavioral therapy for 
childhood anxiety in 
community mental 
health centers. 
Journal of Cognitive 
Psychotherapy, 27(3), 
A pilot 
study 
looking 
at the 
use of 
compute
r driven 
CBT for 
pediatric 
anxiety, 
carried 
out 
through 
N=17. 
Ages; 
7-13 
years 
Level 3; 
Pilot 
study 
Pilot study, 
small 
sample size 
12 sessions of 
interactive 
computer 
driven CBT 
derived from 
the Coping Cat 
protocol 
73% were 
treatment 
responders. 
Child and parent 
scored high for 
satisfaction of 
delivery of CBT 
There is high 
success in anxiety 
remission with the 
use of CBT if 
patients have 
access. This study is 
one that draws 
attention to the 
multiple means for 
carrying out CBT for 
the management of 
pediatric anxiety.  
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221-234. 
https://doi.org/10.18
91/0889-
8391.27.3.221  
communi
ty 
centers 
De Souza, M., Augusta 
Mansur, Salum, G. A., 
Jarros, R. B., Isolan, L., 
Davis, R., Knijnik, D., 
Manfro, G. G., & 
Heldt, E. (2013). 
Cognitive-behavioral 
group therapy for 
youths with anxiety 
disorders in the 
community: 
Effectiveness in low 
and middle income 
countries. Behavioural 
and Cognitive 
Psychotherapy, 41(3), 
255-264. 
https://doi.org/10.10
17/S13524658130000
15  
Evaluate 
use and 
effective
ness of 
CBT in 
low- and 
middle-
income 
countries 
for 
pediatric 
anxiety 
N=28. 
Ages; 
10-17 
years 
Level 3; 
Open 
clinical 
trial 
Small 
sample size 
CBT. 14 
sessions of 
group CBT, 2 
sessions for 
parents using 
Coping Cat 
program. 
PARS, SCARED 
assessment 
tools 
CBT was 
significantly 
effective for 
youth of low- 
and middle-
income 
countries 
Across different 
socioeconomic 
classes, CBT is 
effective in 
management of 
anxiety if access is 
available 
Ege, S., & Reinholdt-
Dunne, M. L. (2016). 
Improving treatment 
response  
for paediatric anxiety 
disorders: An 
information-
Explorato
ry review 
of 
literature 
on 
pediatric 
anxiety 
NA Level 3; 
Observati
onal 
study 
Selective 
rather than 
exhaustive 
analysis 
NA Categories 
potential 
limitations of 
utilizing CBT for 
pediatric anxiety 
Offers how 
limitations and 
barriers to 
obtaining CBT may 
be addressed in 
clinical practice 
       55 
 
processing 
perspective. Clinical 
Child & Family 
Psychology Review, 
19(4), 392–402. 
https://doi.org/10.10
07/s10567-016-0211-
4  
including 
CBT 
Galla, B. M., Wood, J. 
J., Chiu, A. W., Langer, 
D. A., Jacobs, J., 
Ifekwunigwe. M., & 
Larkins, C.  
(2012). One year 
follow-up to modular 
cognitive behavioral 
therapy for the 
treatment of pediatric 
anxiety disorders in an 
elementary school 
setting. Child 
Psychiatry and Human 
Development, 43(2), 
219–226. 
https://doi.org/10.10
07/s10578-011-0258-
x  
Evaluate 
long-
term 
effect of 
CBT 
N=24. 
Ages; 
5-12 
years 
Level 2; 
RCT 
Small 
sample size. 
Participants 
were from 
previous 
trial 
conducted 
by same 
authors 
CBT. Trained 
independent 
persons 
conducted 
diagnostic 
interviews 
before CBT 
treatment, 
post treatment 
and 1 year 
later. 
Tools included; 
MASC-C and 
MASC-P 
There is ongoing 
benefit 1-year 
post CBT. 71.4% 
of participants 
had positive 
response 1 year 
following 
treatment. 
83.3% were free 
of anxiety 
diagnosis. 
CBT may have 
lasting effect on 
anxiety and may 
remove diagnosis.  
Research should 
look at 
implementing 
interventions 
within elementary 
school setting. 
Gibby, B., Casline, E., 
& Ginsburg, G. (2017). 
Long-term outcomes 
Shifts 
focus on 
efforts of 
effective 
Age; 
less 
than 18 
years 
Level 5; 
Review 
of 
evidence 
Databased 
included; 
PsycInfo, 
PubMed  
CBT, selective 
serotonin 
reuptake 
inhibitors. 
Review indicates 
long-term 
outcome are 
positive. Half 
Providers long-
term outcome for 
parental and 
patient knowledge 
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of youth treated for 
an  
anxiety disorder: A 
critical review. Clinical 
Child & Family 
Psychology Review, 
20(2), 201–225. 
https://doi.org/10.10
07/s10567-017-0222-
9  
treatmen
t and 
evaluate 
the long-
term 
outcome 
from 
treatmen
t 
including 
CBT and 
medicati
on 
Evaluates 21 
published 
reports of 
Long-term 
follow up 
cohorts.  
youth no longer 
met anxiety 
diagnosis. 
Mean 
assessment was 
at 5.85 years 
after initial 
treatment 
expectation from 
treatment.  
Gonzalez, A., Peris, T. 
S., Vreeland, A., Kiff, 
C. J., Kendall, P. C., 
Compton, S. N., 
Albano, A. M.,  
Birmaher, B., 
Ginsburg, G. S., 
Keeton, C. P., March, 
J., McCracken, J., 
Rynn, M., Sherrill, J., 
Walkup, J. T., & 
Piacentini, J. (2015). 
Parental anxiety as a 
predictor of 
medication and CBT 
response for anxious 
youth. Child 
Psychiatry & Human 
Evaluate 
impact of 
parental 
anxiety 
on 
pediatric 
anxiety  
N=488. 
Ages;7-
17 
years 
Level 2; 
RCT 
Coping Cat 
program, 14 
sessions 
over 12 
weeks. 
PARS scale 
Cognitive 
Behavioral 
Therapy, 
Sertraline, 
Combo of 
both, placebo.  
Parental anxiety 
was positively 
correlate with 
youth 
depression.  
Youth who received 
both CBT and 
sertraline were 
benefited the most. 
Unexpectedly, 
higher levels of 
parental anxiety 
predicted a better 
symptom trajectory 
for the sertraline 
group. Parental 
anxiety did not 
significantly 
influence trajectory 
of other treatment 
groups. 
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Development, 46(1), 
84–93. 
https://doi.org/10.10
07/s10578-014-0454-
6  
James, A. C., James, 
G., Cowdrey, F. A., 
Soler, A., Choke, A., & 
James, A. C. (2018). 
Cognitive  
behavioural therapy 
for anxiety disorders 
in children and 
adolescents. Cochrane 
Database of 
Systematic Reviews, 
(2). 
https://doi.org/10.10
02/14651858.CD0046
90.pub4  
Review 
of 
literature 
looking 
at CBT 
for 
anxiety in 
children 
and 
adolesce
nts.  
Assess 
CBT vs 
placebo 
vs 
medicati
on. Looks 
at long-
term 
effect of 
CBT 
NA Level 1: 
Review 
41 studies 
were 
reviewed. 
Review of 
RCTs. 
Interventions 
varied 
between the 
41 studies 
reviewed. 
CBT is an 
effective 
treatment for 
anxiety. Limited 
information 
surrounding if 
CBT is more 
effective than 
medication 
More studies are 
needed to evaluate 
the difference 
between 
effectiveness in 
treatment 
approaches for 
anxiety. 
Lenhard, F., Ssegonja, 
R., Andersson, E., 
Feldman, I., Rück, C., 
Mataix-Cols, D., & 
Serlachius, E.  
Evaluate 
cost 
effective
ness of 
internet-
N= 67. 
Ages; 
12-17 
years 
Level 2; 
Single 
blinded 
RCT 
Study 
performed 
at single 
research 
clinic 
12-week 
therapist 
guided ICBT vs 
waitlist 
condition 
ICBT is cost 
saving. Savings 
mainly 
attributed to 
reduced 
Results suggest 
ICBT is cost 
effective and 
should be 
implemented in 
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(2017). Cost-
effectiveness of 
therapist-guided 
internet-delivered 
cognitive behaviour 
therapy for paediatric 
obsessive-compulsive 
disorder: Results from 
a randomised 
controlled trial. BMJ 
Open, 7(5), 1. 
https://doi.org/10.11
36/bmjopen-2016-
015246  
based 
CBT 
healthcare use 
of CBT 
practice with 
consideration to 
the strain on 
healthcare budget   
Masi, G., Pfanner, C., 
Mucci, M., Berloffa, S., 
Magazu, A., Parolin, 
G., Perugi, G. (2013). 
Pediatric  
social anxiety 
disorder: Predictors of 
response to 
pharmacological 
treatment. Brown 
University Child & 
Adolescent 
Psychopharmacology 
Update, 15(2), 7. 
https://doi.org/10.10
89/cap.2012.0007  
Evaluatin
g 
predictor
s of 
successfu
l 
pharmac
ological 
treatmen
t for 
pediatric 
anxiety 
N=140. 
Ages; 
7-18 
years 
Level 4; 
Case 
controlle
d study 
NA SSRIs vs 
psychotherapy 
+ SSRIs.  
72.8% of 
psychotherapy 
+SSRI responded 
after 3 months 
of treatment. 
50.8% responder 
with medication 
alone. 
More severe forms 
of anxiety linked to 
poorer prognosis, 
dual therapy or 
SSRI + CBT may be 
best approach 
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McGuire, J. F., 
Caporino, N. E., Palitz, 
S. A., Kendall, P. C., 
Albano, A. M., 
Ginsburg, G. S.,  
Birmaher, B., Walkup, 
J., & Piacentini, J. 
(2019). Integrating 
evidence-based 
assessment into 
clinical practice for 
pediatric anxiety 
disorders. Depression 
& Anxiety, 36(8), 744–
752. 
https://doi.org/10.10
02/da.22900  
Assess 
whether 
use of 
evidence-
based 
practice 
enhance 
therapist 
judgeme
nt and 
therapeu
tic 
improve
ment  
N=436. 
Ages; 
7-17 
years 
Level 2; 
RCT 
Participants 
were from 
Child/Adole
scent 
Multimodal 
Study 
Medication, 
CBT, placebo. 
Anxiety scales 
included 
SCARED, MASC 
Optimal 
approach to 
determining 
treatment 
response 
includes 
therapist and 
parent reporting 
Parent reporting 
measures should 
be included in 
clinical practice to 
evaluate pediatrics 
response to 
therapy 
Nordh, M., Vigerland, 
S., Öst, L., Ljótsson, B., 
Mataix-Cols, D., 
Serlachius, E., & 
Högström, J.  
(2017). Therapist-
guided internet-
delivered cognitive-
behavioural therapy 
supplemented with 
group exposure 
sessions for 
adolescents with 
social anxiety 
Evaluates 
feasibility 
and 
effective
ness of 
therapist 
guided 
internet 
CBT with 
supplem
ented 
group 
sessions 
N=30. 
Ages; 
13-17 
years 
Level 3; 
Open 
observati
onal 
clinical 
trial 
Study was 
conducted 
at a 
psychiatric 
research 
participant. 
SAD 
diagnosis 
12 weeks of 
intervention. 9 
therapist 
guided 
internet CBT. 3 
group sessions. 
5 internet 
parents’ 
sessions 
Results revealed 
significant 
decrease in 
clinician, 
adolescent and 
parent rated 
anxiety. 47% of 
participants no 
longer met 
anxiety criteria. 
Adolescents 
were satisfied 
with internet 
treatment 
Internet therapy 
guided CBT appears 
to be cost effective 
as well as 
management 
effective. 
Additionally, 
resonates with 
adolescent 
population 
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disorder: A feasibility 
trial. BMJ Open, 7(12), 
1. 
https://doi.org/10.11
36/bmjopen-2017-
018345  
Norman, K. R., 
Silverman, W. K., & 
Lebowitz, E. R. (2015). 
Family 
accommodation of 
child and  
adolescent anxiety: 
Mechanisms, 
assessment, and 
treatment. Journal of 
Child & Adolescent 
Psychiatric Nursing, 
28(3), 131–140. 
https://doi.org/10.11
11/jcap.12116  
Evaluates 
ways in 
which 
family 
accomm
odations 
impact 
anxiety 
manage
ment 
given 
substanti
al 
number 
of 
children 
do not 
respond 
to 
treatmen
t 
NA Level 3; 
Observati
onal 
Pubmed 
and Psyc-
INFO were 
the sources 
used for lit 
search 
Family 
accommodatio
n meaning 
ways parents 
adapt their 
own behavior 
to reduce 
children’s 
anxiety  
Family 
accommodation 
is common 
among pediatric 
anxiety disorder 
and has a 
potential 
negative impact 
on illness 
Incorporating 
parent involvement 
in treatment may 
not only help with 
outcome but may 
address barriers 
and relapse 
Salloum, A., Johnco, 
C., Lewin, A. B., 
McBride, N. M., & 
Assesses 
barriers 
to 
receiving 
N=100. 
Age; 7-
13 
years 
Level 2; 
RCT 
Computer-
assisted CBT 
Community 
based RCT 
utilizing 
computer-
Most common 
barrier was 
parents not 
knowing where 
Accessibility, time 
efficiency and cost 
should strongly be 
considered when 
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Storch, E., A. (2016). 
Barriers to access  
and participation in 
community mental 
health treatment for 
anxious children. 
Journal of Affective 
Disorders, 196, 54–61. 
https://doi.org/10.10
16/j.jad.2016.02.026  
CBT for 
anxiety in 
the 
pediatric 
populatio
n. 
assisted CBT. 
Assess barriers 
of treatment 
completers vs 
non 
completers  
to seek services 
(66%). 
Difference 
between 
completers and 
non-completers 
was stigma, 
confidentiality 
and cost. 
implementing CBT 
for anxiety in order 
for compliance and 
treatment success. 
Walkup, J. T., Albano, 
A. M., Piacentini, J., 
Birmaher, B., 
Compton, S. N., 
Sherrill, J. T., 
Ginsburg,  
G., Rynn, M., 
McCracken, J., 
Waslick, B., Lyengar, 
S., March, J. S., & 
Kendall, P. C. (2008). 
Cognitive behavioral 
therapy, sertraline, or 
a combination in 
childhood anxiety. 
The New England 
Journal of Medicine, 
359(26), 2753-66. 
https://doi.org/10.10
56/NEJMoa0804633  
One of 
the initial 
big 
studies 
to 
evaluate 
the 
effective
ness of 
treatmen
t options 
for 
pediatric 
anxiety 
N=488. 
Age; 7-
17 
years 
Level 2; 
RCT 
NA Participants 
received 14 
sessions of 
CBT, sertraline 
(up to 
200mg/day), 
combo or 
placebo 
80.7% 
improvement 
with 
combination 
therapy. 59.7% 
for CBT and 
54.9% for 
sertraline. 
Placebo 23.7%. 
Combination 
was superior, 
followed by CBT 
Combination 
therapy with both 
CBT and sertraline 
were significantly 
better than either 
alone, though CBT 
was more effective 
as monotherapy 
then sertraline. 
Barriers need to be 
addressed so 
patients can utilize 
the combination 
therapy. 
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Wehry, A. M, Beesdo-
Baum, K., Hennelly, 
M. M., Connolly, S. D., 
& Strawn, J. R. (2015).  
Assessment and 
treatment of anxiety 
disorders in children 
and adolescents. 
Current Psychiatry 
Reports, 17(7). 
https://doi.org/10.10
07/s11920-015-0591-z     
 
Review 
of 
childhoo
d anxiety 
manage
ment, 
outcome 
and 
trajector
y. 
NA NA NA CBT, 
mindfulness, 
SSRIs, SNRIs, 
TCAs 
Summary of 
current 
modalities for 
treating fear-
based anxiety in 
the pediatric 
population 
Provides a 
thoughtful review 
of fear-based 
anxiety disorders in 
the pediatric 
population. 
Identifies that 
certain clinical and 
demographic 
variables may 
predict successful 
treatment 
outcomes 
Zehgeer, A., Ginsburg, 
G. S., Lee, P., 
Birmaher, B., Walkup, 
J., Kendall, P. C., 
Sakolsky, D., Peris, T.  
(2018). 
Pharmacotherapy 
adherence for 
pediatric anxiety 
disorders: Predictors 
and relation to child 
outcomes. Child & 
Youth Care Forum, 
47(5), 633-644. 
https://doi.org/10.10
07/s10566-018-9459-
9  
Evaluates 
adherenc
e to 
evidence-
based 
treatmen
t of 
pediatric 
anxiety 
N=349, 
Age; 7-
17 
years 
Level 2; 
RCT 
Pharmacoth
erapist used 
to measure 
pharmacoth
erapy 
adherence 
Sertraline, 
placebo, 
sertraline + 
CBT. 12 weeks 
follow 
through. 
Few significant 
predictors of 
adherence. 
Greater 
adherence when 
living with two 
parents and 
parents’ positive 
expectation of 
possible 
outcome 
Study highlights the 
importance of 
shared decision 
making, adherence 
improved by hope 
and belief of 
positive outcome 
from treatment 
plan 
